A127120 logo

JS Link, Inc. Stock Price

KOSDAQ:A127120 Community·₩604.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A127120 Share Price Performance

₩0
-4175.00 (-100.00%)
₩0
-4175.00 (-100.00%)
Price ₩0

A127120 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet with low risk.

3 Risks
0 Rewards

JS Link, Inc. Key Details

₩16.1b

Revenue

₩14.0b

Cost of Revenue

₩2.1b

Gross Profit

₩14.5b

Other Expenses

-₩12.4b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-390.55
13.04%
-76.89%
74.0%
View Full Analysis

About A127120

Founded
2000
Employees
83
CEO
Jong-Eun Lee
WebsiteView website
jslink.co.kr

JS Link, Inc., a genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally. Its next generation sequencing services include whole genome sequencing, De Novo sequencing, whole exome/targeted sequencing, transcriptome sequencing, epigenome sequencing, and single-cell RNA sequencing. The company also provides microarray services, such as DNA and microarray RNA analysis; Fluidigm BioMark System, an automated PCR/qPCR system; TaqMan assay; and SNaPshot assay. In addition, it provides rare earth and permanent magnets. The company was formerly known as DNA Link, Inc. and changed its name to JS Link, Inc. in April 2025. JS Link, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Recent A127120 News & Updates

JS Link, Inc.'s (KOSDAQ:127120) 26% Price Boost Is Out Of Tune With Revenues

Oct 10
JS Link, Inc.'s (KOSDAQ:127120) 26% Price Boost Is Out Of Tune With Revenues

Recent updates

No updates